Experienced in Vaginal Bleeding Between Periods

Dr. Cheung Wong

Gynecologic Oncology | Obstetrics and Gynecology | Oncology
University Of Vermont Medical Center Inc
111 Colchester Ave, 
Burlington, VT 
Accepting New Patients
Offers Telehealth
Experienced in Vaginal Bleeding Between Periods
University Of Vermont Medical Center Inc
111 Colchester Ave, 
Burlington, VT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Cheung Wong is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Burlington, Vermont. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Vaginal Bleeding Between Periods. His top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Malignant Mixed Mullerian Tumor, and Salpingo-Oophorectomy. Dr. Wong is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Obstetrics and Gynecology
Oncology
Licenses
Obstetrics & Gynecology in VT
Hospital Affiliations
Elizabethtown Community Hospital
Champlain Valley Physicians Hospital Medical Ctr
Univ. Of Vermont - Fletcher Allen Health Care
Central Vermont Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

UNIVERSITY OF VERMONT MEDICAL CENTER INC
111 Colchester Ave, Burlington, VT 05401
Other Locations
UNIVERSITY OF VERMONT MEDICAL CENTER INC
1 S Prospect St, Burlington, VT 05401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2024
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Enrollment Status: Unknown
Publish Date: February 19, 2018
Intervention Type: Other, Behavioral
Study Phase: Phase 3
View 5 Less Clinical Trials

5 Total Publications

Management of secondary Paget's disease of the vulva associated with transitional cell carcinoma.
Management of secondary Paget's disease of the vulva associated with transitional cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: March 27, 2022
Similar Doctors
Advanced in Vaginal Bleeding Between Periods
Dr. Maria G. Carracino
Obstetrics and Gynecology
Advanced in Vaginal Bleeding Between Periods
Dr. Maria G. Carracino
Obstetrics and Gynecology

Champlain Obstetrics And Gynecology, P.C.

55 Main St, Suite 3, 
Essex Junction, VT 
 (4.4 miles away)
802-879-1802
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Maria Carracino is an Obstetrics and Gynecologist in Essex Junction, Vermont. Dr. Carracino is rated as an Advanced provider by MediFind in the treatment of Vaginal Bleeding Between Periods. Her top areas of expertise are Vaginal Bleeding Between Periods, Female Genital Sores, Fetal Enterovirus Syndrome, Polycystic Ovary Syndrome, and Intrauterine Device Insertion. Dr. Carracino is currently accepting new patients.

Advanced in Vaginal Bleeding Between Periods
Dr. Jane A. Lowell
Obstetrics and Gynecology
Advanced in Vaginal Bleeding Between Periods
Dr. Jane A. Lowell
Obstetrics and Gynecology

Maitri Health Care For Women PC

185 Tilley Dr, Suite 57, 
South Burlington, VT 
 (2.9 miles away)
802-233-6692
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jane Lowell is an Obstetrics and Gynecologist in South Burlington, Vermont. Dr. Lowell is rated as an Advanced provider by MediFind in the treatment of Vaginal Bleeding Between Periods. Her top areas of expertise are Menorrhagia, Vaginal Cysts, Vaginal Dryness, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Lowell is currently accepting new patients.

Advanced in Vaginal Bleeding Between Periods
Dr. Jennifer D. Wetherald
Obstetrics and Gynecology
Advanced in Vaginal Bleeding Between Periods
Dr. Jennifer D. Wetherald
Obstetrics and Gynecology

Northeastern Vermont Regional Hospital Inc

1315 Hospital Dr, 
Saint Johnsbury, VT 
 (58.5 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Wetherald is an Obstetrics and Gynecologist in Saint Johnsbury, Vermont. Dr. Wetherald is rated as an Advanced provider by MediFind in the treatment of Vaginal Bleeding Between Periods. Her top areas of expertise are Vaginal Bleeding Between Periods, Vaginal Cysts, Vaginal Dryness, Trichomoniasis, and Intrauterine Device Insertion. Dr. Wetherald is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wong's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile